AlphAIAlphAI — Financial news for AI agents
SEC EDGARMAY 291 min read

JW Asset Management, LLC (Wild Jason G.) sold $6.6M of ESTA (indirect holdings)

JW Asset Management, LLC sold 90,533 indirectly-held shares of ESTABLISHMENT LABS HOLDINGS INC. (ESTA) at an average of $73.31 ($72.50–$74.39, $6.64M total) across 3 trades over 2026-05-26 to 2026-05-28. Filed jointly with JW Partners, LP, JW Opportunities Fund, LLC, JW GP, LLC and Wild Jason G..

Original reporting
SEC EDGAR · JW Asset Management, LLC, JW Partners, LP, JW Opportunities Fund, LLC, JW GP, LLC, Wild Jason G.
Published May 29, 2026, 12:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:43 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$ESTA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale reduces insider ownership and may influence short‑term sentiment.

02

Market read

First‑report insider sell of moderate size; potential short‑term price impact.

03

What to watch

No change in company fundamentals; the insider may have liquidity needs unrelated to outlook.

Relevance 6/10Novelty 4/10Timing: filing date 2026-05-29

Background

SEC Form 4 filing provides the first public record of the insider transaction.

Market effects

Sector

May raise concerns for biotech sector investors tracking insider activity.

Regional

Limited to U.S. markets where EST trades.

Global

Minimal global impact.

Counterpoint

What could challenge this read

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • company
    Establishment Labs Holdings Inc.

    Biotech firm listed on Nasdaq under ticker EST.

  • insider
    JW Asset Management, LLC

    Reporting entity executing the share sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ESTA insider trading history →

Related articles

AUG 8
$ESTAMed

Establishment Labs Q2 Earnings Call Highlights

Establishment Labs (NASDAQ:ESTA) reported Q2 updates on its Motiva breast implant business. Outside the U.S. revenue rose 4.4% to $42.8M, with Europe up 16%. Its Minimally Invasive platform generated $12.1M revenue, nearing 15% of full-year global revenue. Gross margin improved to 70.6%. Cash was $71.2M. FDA site audits began for U.S. reconstruction; no material revenue expected until 2027.

yahoo.com6 min
AUG 6
$ESTAMed

Establishment Labs® Reports Second Quarter 2026 Financial Results

ESTABLISHMENT LABS HOLDINGS INC. (ESTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 PRESS RELEASE Investor/Media Contact: Malavika William mwilliam@establishmentlabs.com Establishment Labs ® Reports Second Quarter 2026 Financial Results NEW YORK, NY, August 6, 2026 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology compa

SEC EDGAR 8-K3 min